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Abstract
Background: Deficiency of the PERK eIF2α kinase in humans and mice results in postnatal
exocrine pancreatic atrophy as well as severe growth and metabolic anomalies in other organs and
tissues. To determine if the exocrine pancreatic atrophy is due to a cell-autonomous defect, the
Perk gene was specifically ablated in acinar cells of the exocrine pancreas in mice.
Results: We show that expression of PERK in the acinar cells is required to maintain their viability
but is not required for normal protein synthesis and secretion. Exocrine pancreatic atrophy in
PERK-deficient mice was previously attributed to uncontrolled ER-stress followed by apoptotic cell
death based on studies in cultured fibroblasts. However, we have found no evidence for
perturbations in the endoplasmic reticulum or ER-stress and show that acinar cells succumb to a
non-apoptotic form of cell death, oncosis, which is associated with a pronounced inflammatory
response and induction of the pancreatitis stress response genes. We also show that mice carrying
a knockout mutation of PERK's downstream target, ATF4, exhibit pancreatic deficiency caused by
developmental defects and that mice ablated for ATF4's transcriptional target CHOP have a normal
exocrine pancreas.
Conclusion: We conclude that PERK modulates secretory capacity of the exocrine pancreas by
regulating cell viability of acinar cells.
Background
Acinar cells of the exocrine pancreas synthesize and store
copious quantities of the major digestive enzymes, poised
to respond to episodic feeding events. Pro-enzymes
(zymogens) are processed and folded in the rough endo-
plasmic reticulum and Golgi complex and are packaged
into zymogen granules. Binding of a secretagogue such as
cholecystokinin or acetylcholine to its receptors initiates
Ca2+  signaling and results in regulated exocytosis of
zymogens into the duct. However, abnormal signaling
caused by various factors including hyper-stimulation
with high doses of secretagogues can activate zymogens
prematurely in the pancreas, which results in autodiges-
tion of the cells and acute pancreatitis.
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Previously we [1], and others [2] have independently
showed that the lack of PERK (EIF2AK3) in mice results in
atrophy of the exocrine pancreas. This is consistent with
earlier findings of pancreatic insufficiency in Wolcott-Ral-
lison syndrome, a rare autosomal recessive disorder
caused by a mutation in the human Perk gene [3,4]. PERK
is an endoplasmic reticulum (ER)-resident kinase that
phosphorylates eukaryotic translation initiation factor 2α
(eIF2α) [5,6]. Hyper-activation of PERK in cultured cells
by pharmacological ER-stress inducers results in global
repression of protein synthesis and translational induc-
tion of ATF4 [7-9]. This, in turn, induces the transcription
of GADD153/CHOP. Consequently, the observed atro-
phy of the exocrine pancreas, as well as the loss of the
insulin-secreting β-cells of the endocrine pancreas, in the
PERK-deficient animals was interpreted as a defect in the
unfolded protein response (UPR) which resulted in
uncontrolled ER-stress, followed by apoptotic cell death
[2,10]. However, there is no direct evidence for uncon-
trolled ER-stress and apoptotic cell death in the exocrine
pancreas of mice with knockout mutations of Perk (PKO),
and recently the diabetes associated with PERK-deficiency
in mice was shown to be caused by a proliferation and dif-
ferentiation defect of the insulin secreting β-cells during
fetal and neonatal development and not because of
uncontrolled ER stress[11]. A confounding problem in
assessing the defects in the exocrine pancreas of PKO mice
is that a multitude of severe neonatal defects occur in
other organs and tissues prior to the detection of overt
anomalies in the exocrine pancreas[1,11]. These defects,
which occur earlier in development, make it impossible to
ascertain whether the anomalies occurring in the exocrine
pancreas of PKO mice are cell-autonomous or secondary
to dysfunctions in other organs.
To elucidate the mechanisms underlying the cell death
and atrophy of the exocrine pancreas of the PKO mice, we
have generated a pancreatic acinar cell-specific knockout
mutation of the Perk gene (exPKO) in mice using the Cre-
loxP system and have examined the critical physiological
functions, the ER-stress pathway, and the mode of cell
death in acinar cells.
Results
PERK is cell-autonomously required in the exocrine 
pancreas
We generated pancreatic acinar cell-specific Perk knockout
mice by crossing a mouse carrying Cre recombinase driven
by the Elastase-1 promoter ("Ela-Cre") [12] to a mouse car-
rying a floxed Perk gene [1]. The Elastase-1 promoter directs
expression specifically in the rodent exocrine pancreas
[12-14]. The tissue-specific knockout mice (exPKO; Ela-
Cre h+; Perk flox/flox) showed a high CRE-mediated
recombination rate (average 64.7% ± 0.06 [s.d.]) in the
total pancreas at postnatal day 11 (P11). Since 7–8% of
the total pancreas is comprised of other cell types we esti-
mate that 70% of acinar cells contained the deletion of
Perk. The fraction of phosphorylated eIF2α (to total
eIF2α) in the exPKO pancreas is reduced to approximately
50% of wild-type at P42 but is somewhat higher than
what is seen in PKO mice of the same age.
The  exPKO  and wild-type pups from crosses of exPKO
(Ela-Cre h+; Perk flox/flox) × Perk flox/flox were born at the
expected 1:1 Mendelian ratio. Unlike the PKO mice, the
exPKO mice were fertile and indistinguishable in appear-
ance from their wild-type littermates. Before P15, both
PKO and exPKO mice showed normal exocrine pancreatic
histology and expression levels of pancreatic amylase
mRNA and protein (data not shown) were similar to that
of wild-type animals. Proliferation of exPKO acinar cells
was also normal as measured by BrdU incorporation
(based on 4 mutant and 3 wild-type pancreata at P12-14;
P = 0.63 [n.s.] by Student's t-test). However, at postnatal 3
weeks (typically at P19), the exocrine pancreas of both
PKO and exPKO mice exhibited structural disorganization
and cell death (Figure 1A to 1D). At this postnatal age
12% (± 0.09 [s.d.]) of the acinar cells were swollen and
degranulated, lacking the intense staining of zymogen
granules, and had abnormal nuclei with varied content
density (Fig. 1D). The distribution of these cells was ran-
dom across the entire pancreas. Initially defective cells
were observed sporadically, and the number of acini con-
taining those cells as well as the number of defective cells
per acinus increased progressively across the entire exo-
crine pancreas without a particular pattern. Although the
age of mutant phenotype onset varied, the cellular defect
appeared by P25 with nearly complete penetrance.
Because of extensive acinar cell death, the size of the pan-
creatic mass decreased with age. By 3–4 months, acinar
cells were no longer the major cell type of the exocrine
pancreas and had been replaced by fibroblasts, adi-
pocytes, and macrophages/leukocytes (Figure 1E, F). Infil-
tration of macrophages and leukocytes was confirmed by
staining for acid phosphatase, a marker for lysosomes
enriched in macrophages (Figure 6E, F). A subset of
severely affected mice had what appeared to be dediffer-
entiation of acini into duct-like structures in lieu of the
cell death that was observed in most animals (Figure 1G).
The progression and magnitude of the cellular and molec-
ular abnormalities of the exocrine pancreas were very sim-
ilar in the exPKO and PKO mice, even though 30% of
acinar cells in exPKO were estimated to be wild-type at
P11. Two possible explanations for the equally severe
atrophy in the exPKO mice are that the remaining wild-
type cells (at P11) eventually undergo Cre-mediated dele-
tion or that the dying PERK-deficient cells induce cell
death of the remaining wild-type cells.BMC Cell Biology 2007, 8:38 http://www.biomedcentral.com/1471-2121/8/38
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Unlike the PKO mice that have severely reduced β-cell
mass and become diabetic by P22, the islets of Langerhans
of the exPKO  mice remained morphologically normal
(Figure 1F) and exhibited normal distribution of α-gluca-
gon and β-insulin cells (not shown). In addition the
exPKO mice never became diabetic and exhibited normal
glucose clearance rates at P22, P162 and P231 when sub-
jected to a glucose tolerance test indicating that islet func-
tion was not perturbed (not shown). This was surprising
because few acinar cells remained in these animals to pro-
Acinar cells are lost in both PKO and exPKO mice Figure 1
Acinar cells are lost in both PKO and exPKO mice. The PERK-deficient exocrine pancreas progressively loses acinar 
cells. Acinar cells are tightly packed in wild-type (A, P20). In contrast, PKO acinar cells have become degranulated giving a light 
pink appearance to the cytoplasm in the PKO pancreas (B, P20). The same phenotype is seen in acinar cell-specific PERK knock-
out (C, P19, exPKO). (D) Enlarged views of dying oncotic cells seen in (B) and (C). Some cells have lost nuclear staining (upper 
arrow) while others retain nuclear staining (lower arrow) (E) At P19, this particular exPKO mouse has already lost most of the 
exocrine pancreas although typically this degree of atrophy is not seen until 3–4 months of age. Arrows indicate examples of 
the smaller number of acini remaining. (F) In older mice (P162), acinar cells have been replaced by other cell types including 
adipocytes. Only a few dark pink acini are seen. Islets (arrows) still maintain an apparent normal structure. The animal also 
showed a normal glucose clearance rate. Red arrow indicates a few remaining acini. (G) In some cases, mutant acinar cells ded-
ifferentiate into duct-like structures (P31) with abnormally large centroacinar ducts (black arrows). In the beginning of this 
process, duct cells still contain zymogen granules (right panel, white arrow). In some of these duct-like structures the presump-
tive acinar cells have completely lost zymogen granules (right panel, white arrow). (H) Conditional deletion of the Perk gene in 
3-month-old CreERT2; Perk flox/flox mice also results in the appearance of oncotic cells. Two oncotic acinar cells are enlarged 
(inset) with lower left still exhibiting nuclear staining while the cell in the upper right shows a nuclear ghost. H&E staining. A-C, 
H, 200x; E, 100x; F, 80x; D, G, 600x.BMC Cell Biology 2007, 8:38 http://www.biomedcentral.com/1471-2121/8/38
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vide the structure and typical cellular context for the islets
(Figure 1F). These data suggest that the lack of PERK in
acinar cells specifically affects the exocrine pancreas and
does not contribute to the diabetes that develops in the
PKO mice. In addition, expression of a Perk transgene in
β-cells in the PKO background (β-Perk; PKO; see [15]) res-
cues islet mass and diabetes but not the exocrine atrophy.
Furthermore, tissue-specific Perk  ablation in the entire
pancreas (pcPKO, using Pdx1-Cre) causes both diabetes
and exocrine atrophy; by contrast, mice with gene dele-
tion only in islets (enPKO, using Ngn3-Cre) exhibit diabe-
tes without exocrine atrophy [11]. Thus PERK is required
cell-autonomously in pancreatic acinar cells for their via-
bility, and the multitude of other abnormalities of the
PKO mice do not cause acinar cell death.
Acinar cell death in exPKO  and  PKO  mice typically
appeared around the neonatal-juvenile transition at post-
natal 3 weeks. Numerous developmental and nutritional
changes occur during this interval including a major tran-
sition in diet as pups are weaned from high-fat milk onto
solid chow, which puts new demands on the exocrine
pancreas. To test if the Perk mutant phenotype onset is
affected by the dietary change we postponed weaning
until after P21 when pups were past the age when the
mutant phenotype is typically initiated. We found that
delaying the dietary change that occurs at weaning does
not prevent the progression of exocrine pancreatic atro-
phy in exPKO mice (not shown). To determine if the atro-
phy of the exocrine pancreas in PERK-deficient mice is
developmentally regulated, we utilized a tamoxifen-
inducible Cre-deletor strain targeted to the exocrine pan-
creas (Elastase-CreERT2) to conditionally mutate the Perk
gene in adult mice. Multiple doses of tamoxifen were
administered to 2–3 month-old mice bearing floxed alleles
of Perk and the Elastase-CreERT2 transgene. Several acinar
cells in the tamoxifen-treated mutant mice appeared
degranulated, swollen and lacked normal nuclear content
as observed in the PKO and exPKO mice (Figure 1H). As
expected, the efficiency of CRE-mediated deletion of Perk
was substantially lower than what was observed in the
exPKO pancreas and consequently significantly fewer aci-
nar cells succumbed to cell death. However, both gene
deletion and the cell death were unique to mice carrying
CreERT2; Perk flox/flox that were treated with tamoxifen
and were absent in the tamoxifen-injected wild-type mice
or non-injected controls. Therefore we conclude that
PERK is required for maintaining the viability and func-
tion of the adult exocrine pancreas.
ExPKO acinar cells show pancreatitis-like phenotypes
To assess global changes in gene expression in the exPKO
mice, we performed microarray analyses on RNA isolated
from whole pancreata using Affymetrix mouse arrays
(430A). The genes that showed the largest increase in the
exPKO  pancreas consistently at both P16 and P19 (as
compared to the wild-type littermates) were the pancre-
atic stress response (PSR) genes including pancreatitis-
The exPKO mice show pancreatitis-like phenotypes Figure 2
The exPKO mice show pancreatitis-like phenotypes. (A) Real-time RT-PCR quantification of pancreatitis markers, Pap, 
Reg and Mac2, in exPKO showing induction in acinar cells at P16-32. Ratio of KO to WT is shown. Each value is either a single 
individual or average of multiple individuals. Variation among individuals is large due to differences in when these genes are 
induced and repressed. All genes were normalized to the levels of tubulin mRNA amplified from the same sample. Wilcoxon 
paired sample sign test and Fisher sign test for the combined data set of these four genes showed highly significant bias (P < 
0.0001, Wilcoxon test and P < 0.001, Signs test) toward increased expression of these genes during the P16–P32 postnatal 
period. (B) The serum amylase level of the exPKO mice is significantly increased in the age group after P18 (*, Student's t-test, P 
< .01). Samples were collected from 14 and 36 exPKO animals (P14-17 and P18-25, respectively). Amylase was assayed enzy-
matically as described in Methods. Average fold-differences are shown (wild-type = 1.0; Error bars = s.e.m).
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associated protein (Pap) and regenerating islet-derived
(Reg) 2 and 3 (see Additional file 1). The magnitude of the
induction was large; for example, Pap was elevated by 26-
fold, and Reg3a and Reg3g were also increased by more
than 10-fold at P19. However by P32 these genes were no
longer increased significantly in the exPKO  pancreas,
which is consistent with the accelerated loss of the acinar
cells and the observation that these are acute-phase
response genes [16]. Real-time quantitative RT-PCR anal-
yses on animals of various ages confirmed that the mRNA
levels of these genes were elevated as early as P16 in
mutant pancreas (Figure 2A). The induction of the PSR
genes was transient as shown by a rapid decline by P32.
The transient induction of the PSR genes was associated
with large variation among exPKO mice. We speculate that
the large variation is exacerbated by the brevity of the
period of induced gene expression. In contrast, few genes
were consistently reduced in the mutant (see Additional
file 2).
Induction of the PSR genes was observed 1–2 days prior to
detection of any other exocrine pancreatic anomalies,
including other hallmarks of acute pancreatitis such as
elevation of serum amylase, cell death, and leukocyte
infiltration. During acute pancreatitis amylase is released
into circulation as acinar cells break down and leak cellu-
lar contents into their surroundings. Thus the presence of
amylase in serum is indicative of acute pancreatitis. Serum
amylase was elevated significantly in exPKO mice as early
as P18 (typically at P19; Figure 2B). Elevation of serum
amylase was tightly correlated with an increase in the
number of acinar cells undergoing cell death. As cell death
progressed, however, serum amylase returned to low but
detectable levels (by P40; data now shown). This is most
likely due to catastrophic loss of acinar cells, which also
occurs in severe cases of chronic pancreatitis [17,18].
Serum amylase elevation and massive cell death were also
accompanied by inflammatory responses. Gene profiling
indicated the presence of an inflammatory response par-
ticularly at P19 and P32. Mutant samples showed a signif-
icant increase in genes predominately expressed in
infiltrating macrophages and neutrophils such as Mac-2
(a macrophage marker), Mmp12 (macrophage elastase),
lysosomal proteins (Lip1 and Hexb), and Lcn2 (neu-
trophil gelatinase-associated lipocalin precursor) (see
Additional file 1; also see Figure 2A for Mac-2).
To summarize, the exPKO exocrine pancreas exhibits char-
acteristics of acute pancreatitis and inflammatory
responses. The induction of the acute PSR genes occurs
first in the exPKO mice, followed by the appearance of a
series of pathologies including cell death, serum amylase
Protein synthesis in exPKO acinar cells Figure 3
Protein synthesis in exPKO acinar cells. (A) Before the onset of massive cell death, protein synthesis is normal in the 
mutant pancreas. The graph shows the average of two independent experiments ([35S]Met/Cys incorporation) with a total of 4 
replicates, using lobules isolated from P17 exPKO and wild-type littermates. TCA-precipitable radioactivity was normalized to 
the protein concentration of total lysate. (B) Protein synthesis in older exPKO mice is significantly reduced. Lobules were iso-
lated from P63 exPKO (lanes 2, 4, 6) and wild-type (lanes 1, 3, 5) littermates and incubated for 0, 30, and 60 minutes with 
[35S]Met/Cys and 10 mg of total protein per lane were separated electrophoretically. The arrow indicates the position of amy-
lase, which is the predominant zymogen in the exocrine pancreas and is readily detectable in whole radiolabeled protein. This 
gel was exposed for a short period and other proteins in this molecular weight range were not visible.
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elevation, and inflammation. These events immediately
preceded an observed increase in the number of cells suc-
cumbing to cell death at the end of the third postnatal
week.
ExPKO acinar cells show no evidence of ER-stress
The widely accepted UPR model predicts that loss of PERK
function results in uncontrolled translation leading to ER
protein overload, up-regulation of the transcriptional arm
of the ER-stress response and ultimately cell death [2]. To
test if loss of PERK causes ER-stress ex vivo we assessed the
characteristic outcomes of the ER-stress response in pan-
creatic lobules. Since PERK is predicted to directly regulate
translation we first asked if protein synthesis was altered
in the exocrine pancreas of PERK-deficient mice. Pulse-
labeling experiments were conducted in lobules isolated
from mice just prior to when overt cytological changes are
first seen in mutants (P17) and protein synthesis rates
were calculated. The protein synthesis rate for pancreatic
lobules from P17 exPKO mice was indistinguishable from
wild-type littermates, however, it was significantly dimin-
ished in older mutant animals (P63) (Figure 3A, B). The
latter result is most likely due to the reduction in the
number of acinar cells at this age.
To evaluate the function of the secretory pathway, secret-
agogue-induced exocytosis of amylase was examined in
lobules isolated from P17 mice using 0.5 µM carbachol
(acetylcholine analog). Basal secretion rates were not sig-
nificantly different between the two genotypes and carba-
chol increased amylase secretion in both genotypes with
similar magnitudes and timing (Figure 4A). These results
indicate that the signaling cascade, from receptor recogni-
tion to extracellular release of zymogens, is normal in the
PERK-deficient exocrine pancreas. To further test the func-
tionality of the entire secretory pathway, pulse-chase anal-
ysis was performed using lobules isolated from P17-18
mice. Basal and stimulated secretion rates did not differ
between genotypes, and the transit time of newly synthe-
sized proteins was also similar (Figure 4B). This suggests
that immediately prior to the onset of acinar cell death,
both basal and secretagogue-stimulated secretory func-
tions are normal in the exPKO mice.
Secretion is normal in exPKO acinar cells Figure 4
Secretion is normal in exPKO acinar cells. (A) Amylase secretion. The fraction of secreted amylase to total cellular amy-
lase content was measured enzymatically for both basal and carbachol-stimulated pancreatic lobules. This is a representative 
result from 4 independent experiments. Lobules were isolated from P17 β-Perk; Perk+/+ (WT) and β-Perk; Perk-/- (PKO). The β-
Perk; Perk-/-(PKO) mice are rescued for Perk in endocrine β-cells with all other tissues remaining PERK-deficient, whereas the 
β-Perk; Perk+/+ (WT) control mice harbor the rescuing Perk transgene in an otherwise WT background. The β-Perk; Perk-/- (PKO) 
mice are analogous to the exPKO mice with respect to their exocrine pancreas. Each data point represents three replicate sam-
ples. (B) Pulse-chase analysis of protein secretion. The average of two independent experiments is shown. Lobules were iso-
lated from exPKO (PKO) and wild-type (WT) littermates (P17-18). Lobules were labeled with [35S]Met/Cys as described in 
Figure 3 and then chased in "cold" media over 2 hours. The fraction of TCA-precipitable radioactivity in the media to total cel-
lular TCA-precipitable counts was calculated for each time point for both "basal," (without a secretagogues) and secretago-
gues-stimulated conditions ("Cch"; with 0.5 µM carbachol).
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Previously it was reported that the ER was frequently dis-
tended in PERK-deficient acinar cells [1,2]. This observa-
tion has been interpreted as further evidence that mutant
acinar cells experience unmitigated ER-stress and has also
motivated subsequent studies that link ER distention to
other cellular defects in PERK-deficient acinar cells [19].
However, a detailed histological examination of a greater
number of pancreata revealed that acinar cells exhibiting
lumenal distention were seen in wild-type and exPKO
mice at equal frequency with no ascertainable differences
in morphology (Figure 5A, B). In addition, the frequency
of these cells in the exPKO pancreas did not increase as
atrophy progressed (Figure 5C). Extensive monitoring of
the ER ultrastructure during postnatal development failed
to detect mutant acinar cells that appear to transition from
a luminally distended state to cell death. Cells exhibiting
distended ER by TEM averaged 10% of total immediately
prior to (P16) and after (P25) phenotype onset. Origi-
nally, luminal ER distention in PERK-deficient acinar cells
was claimed as prime evidence for severe abnormality in
protein folding in the ER, leading to cell death in the
mutant exocrine pancreas [1,2]. However, based on our
observations, we conclude that this argument is incorrect.
Finally, in order to assess the level of ER-stress in acinar
cells, the expression of the principal regulatory compo-
nents and markers of ER-stress including BiP, Chop, and
the spliced form of Xbp1  (Xbp1-s) were examined. The
expression of these genes was not significantly altered in
the total pancreas of exPKO mice. At P14-19, the average
fold difference (± s.e.m., sample size) in mutants as com-
pared to wild-type littermates was as follows: BiP, 1.21 (±
0.17, n = 7); Chop, 0.93 (± 0.22, n = 14); Xbp1-s, 1.15 (±
0.17, n = 11). This is consistent with microarray data that
The ER morphology is overall normal in exPKO acinar cells Figure 5
The ER morphology is overall normal in exPKO acinar cells. (A, B) Acinar cells of both wild-type and exPKO pancreata 
exhibit distended and prototypical ER at a similar frequency (A, P16 wild-type, 3000x; B, P16 exPKO, 7500x). (C) An exPKO aci-
nar cell undergoing cell death (oncosis), P25 exPKO, 2500x. (D) The pancreas of the exPKO mouse (P25) contains infiltrating 
macrophages. The arrow points to the ER of an acinar cell engulfed by a macrophage. 1500x. Macrophages were not seen in 
the wild-type pancreas (data not shown). Also see Figure 6 for acid phosphatase staining. (E, F) Images of mutant cells undergo-
ing cell death, 1200x. Note that these still retain the nucleus, which is vacuolated and does not contain chromatin condensa-
tion.BMC Cell Biology 2007, 8:38 http://www.biomedcentral.com/1471-2121/8/38
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showed that expression of ER-resident and ER-stress-
related genes was not significantly different between the
mutant and wild-type pancreata at all ages examined (see
Additional file 3), However, we did detect increases in
mRNA levels of the pancreatic stress response (PSR)
genes, which suggests that had ER-stress functions been
similarly up-regulated we could have readily detected
them as well.
ExPKO acinar cells die through oncosis, not apoptosis
The previously reported high frequency of TUNEL-posi-
tive acinar cells found in PKO mice as early as P18 led to
the conclusion that the mode of cell death was apoptosis
[1,2]. However, it has become increasingly clear that the
TUNEL assay cannot distinguish between apoptosis from
other forms of cell death including oncosis [20-22]. The
visual hallmarks of apoptosis are cellular shrinking and
condensation of chromatin into apoptotic bodies,
whereas oncotic cell death is characterized by cellular
swelling, chromatin fragmentation without formation of
apoptotic bodies, and loss of plasma membrane integrity.
Necrosis has often been used synonymously with oncosis
however it is now generally accepted that necrosis prop-
erly describes the morphological alterations that appear
after cell death has occurred regardless of the mechanism
[23]. TEM analyses on the mutant pancreata failed to
detect apoptotic bodies despite the appearance of numer-
ous TUNEL-positive cells by P25 (see Figure 6B). Instead,
acinar cells in the P25 mutant pancreas undergo vacuola-
tion followed by karyolysis (Figure 5C–F) which are char-
acteristic of oncosis (reviewed in [24]). Closer observation
revealed two distinct TUNEL staining patterns. In both
wild-type and mutant acinar cells a very small fraction (<
0.1%) of acinar cells exhibited intensely stained nuclei
and fragmented nuclei, which are characteristic of apop-
totic nuclear bodies. The fraction of cells exhibiting such
TUNEL positive nuclei did not differ between genotypes.
In contrast in exPKO  acinar cells, a high frequency of
TUNEL positive cells were observed to have diffuse stain-
ing throughout both the nucleus and cytoplasm (Figure
6A, B), consistent with the loss of nuclear membrane
integrity. Furthermore, microarray analysis did not detect
increased expression of apoptosis-related genes before,
during, or after the peak period of cell death in the exo-
crine pancreas (P16, 19, and 32; see Additional file 4).
During the peak period, up to 6% of the mutant acinar
cells were TUNEL-positive and at this frequency apopto-
sis-related genes should have been readily detected had
they been up-regulated in the exPKO pancreas. Instead, all
array data indicated a significant induction of inflamma-
tory genes in the mutant pancreas but not apoptotic genes
(see Additional file 1). Of the genes that showed 2-fold or
higher elevation in the P19 mutant pancreas, 38% were
related to inflammatory, immune, or acute PSR responses.
An additional distinguishing characteristic of oncotic cells
is the loss of plasma membrane integrity that ultimately
leads to inflammatory responses [24,25]. We developed a
new technique to assess plasma membrane integrity in
whole animal tissues based on the normal exclusion of
the serum proteins apolipoprotein E, albumin, and IgG.
In the normal exocrine pancreas, serum proteins are only
found in the vasculature; however, in exPKO mice, serum
proteins were detected in the degranulated acinar cells
undergoing oncotic cell death (Figure 6C, D). Although
serum proteins were abundantly detected in these cells,
the mRNA levels were not elevated (not shown), thus
eliminating the possibility of ectopic gene expression of
these proteins. This observed loss of plasma membrane
integrity as indicated by the passive uptake of serum pro-
teins further substantiates our conclusion that the exPKO
acinar cells succumb to oncosis. If apoptotic, the cells
would have retained their plasma membrane integrity and
been rapidly eliminated thus avoiding the induction of an
acute inflammatory response. However, the degranulated
acinar cells typically persisted for a few days before being
phagocytosed, and the induction of an inflammatory
response was clearly evident. Large numbers of infiltrating
macrophages and neutrophils were detected in the exPKO
pancreas by both acid phosphatase staining (Figure 6E, F),
and by TEM (Figure 5D). Gene profiling also showed that
transcripts for macrophage- and neutrophil-marker genes
were elevated in the mutant pancreas (see Additional file
1). Phagocytosis of oncotic acinar cells by macrophages in
mutant pancreata was also frequently observed by TEM
(Figure 5D).
ATF4-deficient mice exhibit defects in the development of 
the exocrine pancreas
The translation of the ATF4 transcription factor is posi-
tively regulated by PERK activation in cultured fibroblasts
subjected to ER-stress and results in the transcriptional
upregulation of GADD153/CHOP. Consequently, ATF4
and CHOP have been considered to be prime targets of
PERK-mediated regulation in vivo [7]. However, compre-
hensive evidence for this contention is lacking so we
Table 1: Gene expression in neonatal Atf4 KO mice as compared 
to wild-type littermates
BiP Chop Xbp1-s Reg2 Pap Mac-2
Fold 
difference
0.84, 
n.s.
0.71, 
n.s.
0.83, 
n.s.
0.08* 4.93
**
1.01, n.s.
n.s.= not significant
*P = 0.01
**P = 0.03
The ratios of KO to WT expression levels for P6-15 are shown. 
Statistically significant expression differences were determined by 
Student's t-test. The levels of all genes were normalized to a-tubulin, 
except Xbp1-s, which was normalized to Xbp1-t. For WT n = 6 and 
for KO n = 5.BMC Cell Biology 2007, 8:38 http://www.biomedcentral.com/1471-2121/8/38
Page 9 of 16
(page number not for citation purposes)
applied a genetic approach to ask if ATF4 and CHOP par-
ticipate in the PERK's regulation of exocrine pancreas via-
bility. First we examined Atf4  and  Chop KO mice to
determine if they displayed the same pancreatic defects as
Perk KO mice.  Atf4 KO mice exhibit postnatal growth
retardation and are blind due to defective lens develop-
ment [26,27]; however, pancreatic defects were not previ-
ously described. Surprisingly we found that the exocrine
pancreata of neonatal (P4) Atf4 KO mice were severely
underdeveloped and the number of acini and acinar cell
size were greatly reduced (Figure 7). Typically, early neo-
natal mice have a large exocrine pancreatic mass with
individual acini nearly contiguous, and as they mature,
the acini become tightly packed. In contrast, the pancre-
atic acini of Atf4 KO mice were dispersed and often were
not in close proximity to neighboring acini resulting in an
expanded extracellular space. Moreover, Atf4 KO acinar
cells appeared smaller with substantially less zymogen
granule content, which correlated with an increase in the
diameter in the centroacinar duct (Figure 7). In adults the
centroacinar duct was greatly expanded resulting in highly
tubular appearance of the exocrine pancreas. Adult Atf4
KO  pancreata contained numerous adipocytes that
appeared to have taken residence in the expansive extra-
cellular space seen earlier in neonatal mice.
To determine if the reduction in acinar cell number in Atf4
KO mice was a consequence of cell death, TUNEL immu-
nohistochemistry was performed. Unlike PERK-deficient
mice, no increase in TUNEL-positive acinar cells was
observed in Atf4 KO mice. As ATF4 is noted to regulate ER-
stress response genes such as BiP, Chop, and Xbp1-s  in
fibroblasts, we measured the mRNA levels of these genes
in Atf4 KO and wild-type pancreata to see if this regulation
holds true for this tissue (Table 1). No significant differ-
ences were seen between Atf4 mutant mice and wild-type
littermates for these ER-stress-related genes. To determine
if Atf4 KO pancreata exhibit an inflammatory response
similar to exPKO mice, the expression of Reg2, Pap, and
Mac-2 mRNAs was quantified. Surprisingly, Reg2, which is
potently up-regulated in exPKO mice, was substantially
down-regulated in Atf4 KO mice. Pap was induced in the
pancreas of Atf4 KO neonatal mice whereas Mac-2, a mac-
rophage marker, was not induced.
CHOP upregulation is distal to both PERK and ATF4 acti-
vation and is generally considered to be pro-apoptotic,
however, like caspase activation; it may also have a role in
oncosis under certain circumstances [28]. It was therefore
of interest to see if the exocrine pancreas of Chop knockout
mice bore any resemblance to mice deleted for either
exPKO acinar cells die through oncosis Figure 6
exPKO acinar cells die through oncosis. (A, B) Acinar cells in the exPKO pancreas have numerous TUNEL-positive cells 
(A, P31 wild-type; B, P22 exPKO). Note that the TUNEL staining pattern strikingly differs between the two genotypes. TUNEL, 
green; DAPI, blue; background, red. (C, D) Adjacent serial sections (3µ) of the exPKO pancreas (P19). Pale pink (oncotic) acinar 
cells identified by H&E staining (C) correspond to cells positive for ApoE (D); see arrows as an examples of several cells. ApoE, 
red; DAPI, blue; background, green. (E, F) The KO pancreas has significant leukocyte infiltration (E, wild-type; F, exPKO, P74). 
Dark purple acid phosphatase staining indicates infiltrated leukocytes including macrophages (see arrows) in F but not E. The 
background cellular staining is methylene blue.BMC Cell Biology 2007, 8:38 http://www.biomedcentral.com/1471-2121/8/38
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PERK or ATF4. The pancreata of adult Chop KO mice were
found to be completely normal (not shown). To test for
the presence of genetic interactions between Perk and its
putative downstream targets, we generated Atf4+/-; Perk+/
- and Chop+/-; Perk+/- double-heterozygotes. These mice
exhibited normal exocrine and endocrine pancreata (not
shown) thus failing to show a genetic interaction for pan-
creatic development and/or viability.
Although we show for the first time that the exocrine pan-
creas of the Atf4 KO is greatly reduced, the underlying
cause appears to be unrelated to the exocrine pancreas
defect in exPKO mice. The deficiency in exocrine pancreas
mass in Atf4 KO mice was observed early in postnatal
development as a consequence of hypotrophy whereas
the exocrine insufficiency of the exPKO mice was caused
by death of mature acinar cells resulting in atrophy and a
robust inflammatory response.
Discussion
PERK is required for the viability of pancreatic acinar cells
The generation of the exocrine pancreas-specific Perk-
knockout mice enabled us to critically test whether exo-
crine pancreas defects seen in the global PKO mouse are
the direct result of the loss of PERK expression in the aci-
nar cells or are secondary to defects occurring earlier in
other tissues or organs. We found that the exPKO mice
had the same catastrophic loss of acinar cells as seen in
global knockout mice, even though the deletion of Perk in
the exPKO pancreas was incomplete (ca. 70%) at P11. We
surmise that the nearly complete atrophy of the exocrine
pancreas in exPKO is due to continued activity of the aci-
nar-cell targeted Cre enzyme to delete the Perk gene in the
remaining cells over the ensuing days or that the inflam-
matory response causes the death of the remaining wild-
type cells as is seen when NFkappaB is overexpressed [29].
The remarkable consistency in mutant pancreatic pheno-
type among all of the lines that are ablated for Perk in the
exocrine pancreas is a strong indication that expression of
PERK in acinar cells is required for their viability.
Although acinar cell death and atrophy were the predom-
inant outcome of ablating PERK in the exocrine pancreas,
a subset of severely affected animals harbored some acini
that had apparently dedifferentiated into duct-like struc-
tures. This phenomenon is also seen in experimentally-
induced pancreatitis [30] and in animals that have a
genetic block in TGFβ signaling [31,32].
With the exception of the exocrine pancreatic deficiency,
the exPKO mice did not display the other major defects
associated with the Wolcott-Rallison syndrome in
humans and the PKO mice. In some exPKO animals, the
exocrine pancreas was replaced almost entirely by adi-
pocytes, fibroblasts, and leukocytes, and the islets of Lang-
erhans were no longer surrounded by acinar cells. These
animals exhibited normal islet structure and glucose
homeostasis. This demonstrates that the endocrine pan-
creas can survive and function without the exocrine pan-
creas being adjacent. It has been reported that chronic
pancreatitis often results in diabetes, suggesting that dys-
function of the exocrine pancreas has deleterious effects
on the endocrine pancreas (reviewed in [33]). In contrast,
our findings suggest that the loss of the exocrine pancreas
does not necessarily affect viability and function of the
endocrine pancreas.
The onset of pancreatic atrophy in PERK-deficient mice
occurs during the late neonatal stage of development and
is first seen as sporadic degranulation of acinar cells fol-
lowed by extensive cell death within a few days. Given the
early postnatal onset of this atrophy, we considered
whether these defects were dependent upon developmen-
tal age and nutrition. By delaying weaning, we showed
that onset of exocrine pancreas atrophy in exPKO mice
The Atf4 KO mice show pancreatic hypotrophy Figure 7
The Atf4 KO mice show pancreatic hypotrophy. As early as P4, Atf4 KO mice show fewer and smaller acinar cells in the exo-
crine pancreas (A, P4 wild-type; B, P4 Atf4 KO, 400x). The arrows point to tubular structures. By three months of age, the 
majority of the exocrine pancreas is replaced by adipocytes (C, Atf4 KO).BMC Cell Biology 2007, 8:38 http://www.biomedcentral.com/1471-2121/8/38
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was not altered by changing the diet. In addition, we
found that postponing the deletion of the Perk gene in the
exocrine pancreas until the adult stage still lead to oncotic
cell death, thus demonstrating that PERK is essential for
the viability of the adult exocrine pancreas. In contrast,
PERK is required for the fetal development and prolifera-
tion of the insulin-secreting β-cells of the endocrine pan-
creas, but is not required for β-cell viability in mature
adults [11].
The mode of cell death in PERK-deficient exocrine 
pancreas is oncosis
The acinar cells of the exPKO and PKO mice exhibit a dra-
matic increase in cell death. Initially we [1] and others [2]
had proposed that the form of cell death was apoptosis
but this was based entirely upon the detection of DNA
fragmentation in the nuclei of acinar cells using TUNEL
immunohistochemistry. It has been reported that TUNEL
does not distinguish between apoptosis and other forms
of cell death such as oncosis. Therefore, our conclusion
that exPKO acinar cells succumb to oncosis rather than
apoptosis is based primarily on morphological criteria
[20-22]. Oncotic cells are characterized by cell swelling,
vacuolization, chromatin fragmentation without forma-
tion of apoptotic bodies, and increased membrane perme-
ability [24,25]. Fickert and colleagues [22] have recently
shown that oncosis, not apoptosis, is the predominant
form of cholestasis-induced cell death in the liver, and
have provided a set of criteria for distinguishing between
these forms of cell death in animal tissues that we have
used herein.
Our conclusion that the mode of cell death in the PERK-
deficient exocrine pancreas is oncosis derives from our key
findings that include the appearance and progression of
cell-swelling, karyolysis, and loss of plasma membrane
integrity, as well as the induction of an inflammatory
response and the absence of up-regulated apoptotic gene
expression. Apoptotic cell death is often difficult to detect
morphologically owing to the rapid cellular disintegra-
tion and immune clearance of the cells within a few
hours. This rapid clearance and maintenance of plasma
membrane integrity of apoptotic cells is thought to be a
key factor limiting inflammation. In contrast, the oncotic
acinar cells observed in the PERK-deficient exocrine pan-
creas seem to persist for a longer period as "ghost" cells
that have lost plasma membrane integrity, and this may
provide an opportunity for an inflammatory response to
occur.
The exPKO exocrine pancreas exhibits normal protein 
synthesis and secretion without any indication of ER-stress
The major function of PERK has been proposed to be the
repression of global protein synthesis during ER stress and
the activation of translation of specific genes that alleviate
ER stress. Genetic ablation of PERK was therefore pre-
dicted to cause uncontrolled ER stress in normal cells
resulting in heightened ER dysfunction and cell death. The
gross pancreatic abnormalities seen in PERK-deficient
mice, including low insulin-secreting beta cell mass and
exocrine pancreatic atrophy, were initially assumed to
confirm this hypothesis [1,2]. However the neonatal dia-
betes of PERK-deficient mice has been recently shown to
be due insufficient proliferation and differentiation of the
β-cells during fetal and neonatal development [34] and is
not associated with either uncontrolled ER stress or cell
death. In this study we also found that the exocrine pan-
creatic atrophy in PERK-deficient mice is inconsistent
with the hypothesis that it is caused by uncontrolled or
dysfunctional regulation of ER stress. First, protein synthe-
sis and secretion are not significantly impaired in the
mutant exocrine pancreas before or during the early phase
of oncosis, although we assume that individual cells that
have become degranulated and lost plasma membrane
integrity are physiologically dysfunctional. Second, we
did not observe an increase in expression of the major ER-
stress genes. Instead, the genes induced in the mutant
pancreas prior to overt cytological changes are the PSR
genes. Third, knockout mutations in PERK's known
downstream targets, Atf4 and Chop, do not result in cell
death and atrophy of exocrine pancreas. Finally, the struc-
ture of the ER is normal in mutant pancreatic acinar cells
prior to the onset of oncosis and does not exhibit disten-
tion as previously described [2]. Huang and coworkers
[19] recently reported that PERK-deficient pancreatic aci-
nar cells exhibit normal carbachol-stimulated ER Ca2+ sig-
naling as well as normal reloading of Ca2+ following the
response. The ability of exogenously supplied IP3  to
induce ER Ca2+ release was also normal. However, they
did find that the periodicity of the Ca2+ response was
altered in Perk-deficient acinar cells and demonstrated
that mutants have greatly reduced ER- plasma membrane
interactions. They attribute these differences between
mutant and wild-type to the previously reported disten-
tion and fragmentation of the ER in PKO acinar cells [2],
a finding that our data now refutes. Yet overall the results
of this study indicated that the receptor-mediated exo-
crine pathways are functional in Perk-mutant acinar cells,
which is consistent with our finding that secretagogue-
stimulated protein synthesis and secretion are normal in
PERK-deficient acinar cells.
While we did not find evidence that ER stress was associ-
ated with pancreatitis in PERK-deficient mice, other stud-
ies have shown that induction of acute pancreatitis in
wild-type rodents will lead to a classic ER stress response
[35,36]. Caerulein hyperstimulation of acute pancreatitis
in rats results in phosphorylation of eIF2α, and a reduc-
tion in total pancreatic protein synthesis [36], which is
consistent with a potential role for PERK in mediating anBMC Cell Biology 2007, 8:38 http://www.biomedcentral.com/1471-2121/8/38
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ER stress response during an episode of acute pancreatitis.
Another study using the arginine model of acute pancrea-
titis in rats found that all of the principle pathways of ER
stress signaling including PERK activation and eIF2α
phosphorylation were up-regulated and that characteristic
ER stress-related apoptosis appeared shortly thereafter in
the exocrine acini [35]. The differences between these
acute models and what we observe in the exPKO pancreas
may reflect overall differences in how pancreatitis is initi-
ated and progresses. The hallmarks of pancreatic dysfunc-
tion in Perk  mutant mice including the appearance of
acinar cell degranulation, up-regulation of PSR genes and
elevation of serum amylase take at least 2 weeks to appear
whereas changes in pancreatic morphology, gene expres-
sion and the systemic manifestations of acute pancreatitis
occur within hours of induction. It therefore seems rea-
sonable to postulate that the signaling mechanisms
responsible for pancreatitis in PERK-deficient mice differ
from those that regulate the acute form of the disease in
which PERK may participate. Common to all of these
models of pancreatitis is the induction of inflammation
that occurs in response to acinar cell death. In the animal
models of acute pancreatitis inflammation has been com-
monly attributed to acinar cell necrosis; however based
upon cytological descriptions these cells may be more
properly considered oncotic [37].
We propose that PERK is required for the expression of
anti-oncotic or pro-survival factors that are specific to the
exocrine pancreas. PERK resides as a transmembrane pro-
tein kinase with its activation domain in the ER lumen
and catalytic domain in the cytoplasm. PERK's activity is
dynamically regulated by association/disassociation of
the ER chaperone protein BiP/GRP78, whose activity is
regulated by Ca2+ as a cofactor and by ATP as a substrate.
PERK is highly activated by pharmacological reagents that
deplete the ER lumen of Ca2+, and we have shown that
normal secretagogues known to mobilize ER Ca2+ can also
activate PERK under physiological conditions (B.
McGrath and D. R. Cavener, unpublished data). These
data suggest that PERK may be a sensor for Ca2+ mobiliza-
tion from the ER associated with secretory activity. We
speculate that activation of PERK through normal secre-
tory activity results in PERK-dependent regulation of anti-
oncotic or pro-survival factors that maintain the viability
of the acinar cells at adult stages. Necrosis is now generally
regarded as the post-mortem state that results from
uncontrolled cell death whether it arises from oncosis or
as a secondary consequence of failure by the immune sys-
tem to clear apoptotic cells in a timely fashion (secondary
necrosis) [38]. However, recent reports have suggested
that necrosis may also participate in regulated cell death
associated with tissue renewal, embryogenesis, and
immune response [25]. By analogy it is therefore, possible
that a normal oncotic pathway exists in the exocrine pan-
creas and is misregulated in PERK-deficient mice.
Conclusion
PERK is cell-autonomously required for the viability of
the exocrine acinar cells but is not required for their nor-
mal protein synthesis and secretory functions. Perk-defi-
cient acinar cells are lost by an oncotic mechanism of cell
death and not by apoptosis as was originally reported
[1,2]. Acinar death in Perk null mice is not associated with
up-regulation of ER stress functions. Moreover mice carry-
ing mutations in Atf4 or Chop which are known down-
stream targets of PERK signaling during ER stress do not
recapitulate the Perk mutant exocrine phenotype.
Methods
Animals
All the procedures that involved animal subjects were
approved by the Institutional Animal Care and Use Com-
mittee at the Pennsylvania State University to assure
humane treatment of the animals. The knockout and
floxed alleles of Perk in mice were previously described by
us [1]. The floxed Perk allele contains two loxP sites
located in intronic regions flanking three internal exons
encoding segments of the lumenal and transmembrane
domains. Cre-mediated deletion of these exons creates a
frameshift resulting in a null phenotype. Atf4 and Chop
knockout mice were obtained from Dr. Tim Townes, Uni-
versity of Alabama, and Dr. David Ron, New York Univer-
sity, respectively. For developmental stage-specific
deletion of the Perk gene, tamoxifen (SIGMA) solution
(20 mg/ml in corn oil) was injected (i.p.) into the Elastase-
CreERT2 mice (2–3 months old) at 100 µl/animal [39]. To
avoid tamoxifen-induced pancreatitis [40], the chemical
was injected 12 times intermittently over one month.
After 5 days from the last injection, the mice were sacri-
ficed for further analyses.
For weaning-extension, two mating pairs per experiment
(two females and one male) were set up in one large cage.
The resulting litters were kept together with their dams
until pups reached P10 when they were divided randomly
into two cages: one with regular chow (as control) and the
other without chow. Dams were switched between the
two cages every 12 hours to let them access food. Water
was freely accessible to mice in both cages. Conditions
were maintained until the pups reached P25. Pups of the
control group were weaned from the mother at P21, the
normal age for weaning.
Histological studies
Paraffin-embedded tissue was prepared as described pre-
viously [1]. Sections were made at 3–5 µ thickness (3 µ for
serial sections). Fluorescent labeling was carried out using
anti-ApoE (1:250; Santa Cruz) and an appropriate fluores-BMC Cell Biology 2007, 8:38 http://www.biomedcentral.com/1471-2121/8/38
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cently-conjugated secondary antibody (1:500; Molecular
Probes). Nuclei were labeled with DAPI (Molecular
Probes). Cell proliferation was measured by in vivo labe-
ling with 5-bromo-2'-deoxyuridine (BrdU; SIGMA). intra-
peritoneally injected at 50 mg/body weight (kg) Mice
were sacrificed 24 hours post-injection and BrdU incorpo-
ration was detected using anti-BrdU (1:30; DAKO). DNA
fragmentation was detected by TUNEL (TdT-mediated
dUTP Nick-End Labeling; DeadEnd Fluorometric TUNEL
system, Promega) following the manufacturer's protocol.
A leukocyte marker, acid phosphatase, was detected using
Naphthol AS-BI phosphoric acid solution (SIGMA). This
assay was performed on frozen sections (10 µ), of tissues
fixed in 4% phosphate-buffered paraformaldehyde for 2
hours at room temperature and then cryoprotected in
15% sucrose at 4°C overnight. Digital images were cap-
tured using a Nikon E1000 microscope and processed
using the Image Pro (Phase 3 Imaging Systems) software.
The background brightness and contrast were kept equiv-
alent for all images that were directly compared so as not
to distort any apparent differences. Samples for transmis-
sion electron microscopy (TEM) were prepared as
described previously [1].
Amylase assay
Serum samples were separated from cardiac blood and
amylase activity was detected using Amylase Reagent
(RAICHEM) according to the manufacturer's protocol.
The fold difference was calculated by normalizing each
mutant sample to the average of the wild-type samples
within the same litter and the averages of the fold differ-
ence from multiple experiments is presented in Results.
Lobule preparation
Pancreata were excised from mice that had been fasted
overnight, and placed into a Petri dish containing KRB-
HEPES buffer, 5 mg/ml bovine serum albumin (BSA;
SIGMA), and 100 µg/ml soybean trypsin inhibitor (STI;
SIGMA). The KRB-HEPES buffer contained: Krebs-Ringer
bicarbonate (KRB) buffer mix (SIGMA), 0.9 mM CaCl2,
20 mM HEPES, and essential amino acids (GIBCO). The
KRB-HEPES buffer with BSA and STI was injected to the
tissue, and lobules were excised under a dissecting micro-
scope [41].
Protein synthesis and secretion experiments
Approximately 30 lobules per sample were deprived of
methionine and cysteine (Met/Cys) for 10 minutes at
37°C in Met/Cys-free Dulbecco's Modified Eagle
Medium, 20 mM HEPES, Aprotinin (25 µg/ml; SIGMA),
STI (100 µg/ml), and BSA (5 mg/ml). The lobules were
then labeled with [35S]Met/Cys (500 µCi/ml) at 37°C for
15 minutes. The reaction was stopped by the addition of
concentrated non-radioactive Met/Cys solution (0.1 M
each). After lobules were washed twice, chase buffer (KRB-
HEPES buffer with BSA [5 mg/ml], STI [100 µg/ml], and
Aprotinin [25 µg/ml]) and either carbachol (at 0.5 µM) or
water (for control samples) was added. The samples were
incubated in a shaking water bath (37°C; 120 rpm) and
were oxygenated every 15–20 minutes. An aliquot of
buffer was removed at different time points and later
trichloroacetic acid (TCA)-precipitated using ProteoPrep
Protein Precipitation Kit (SIGMA). At the end of the exper-
iment, lobules were washed, homogenized, and total pro-
tein was TCA-precipitated. Precipitates were dissolved in
1% sodium dodecyl sulphate; 0.1 M Tris, pH 8.9, and the
resident radioactivity were measured by scintillation
counting.
The conditions used to measure incorporation of
[35S]Met/Cys into total protein were the same as those
used for the pulse-labeling experiment. All samples were
TCA-precipitated, and the radioactivity was normalized to
the protein concentration of the total lysate.
Measurements of secreted amylase were obtained from
basal and carbachol-stimulated lobules subjected to non-
radioactive "chase" conditions described above. In this
case both buffer aliquots and lobule homogenate were
assayed directly for amylase activity without prior TCA
precipitation.
RNA and DNA preparation
RNA samples were prepared using RNeasy Mini kit (QIA-
GEN). To prevent RNA degradation, the pancreas was
excised and immediately placed in a mortar containing
liquid nitrogen. The frozen tissue was crushed into small
pieces, and homogenized in RLT buffer using QIAshred-
der columns (QIAGEN). The rest of the procedure fol-
lowed the manufacturer's protocol. DNA samples for
Real-time PCR were prepared using DNeasy Tissue kit
(QIAGEN), following the manufacturer's protocol.
Quantification of expression levels
Reverse transcription (RT) was carried out using M-MLV
reverse transcriptase, buffer and Random Primers
(Promega) according to the manufacturer's protocol.
Real-time PCR of cDNA of all genes except Perk was car-
ried out using qPCR Core Kit for SYBR Green I (Eurogen-
tec). Reactions were amplified using the ABI Prism 7000
Sequence Detection System with the following program:
50°C (2 minutes), 95°C (10 minutes), 40 cycles of (95°C
[15 seconds], 60°C [1 minute]). A linear amplification
range was chosen for analyses using ABI Prism 7000 SDS
Software (Applied Biosystems). The dissociation curves
were monitored for the quality and specificity of amplifi-
cation. Levels of Xbp1-s (spliced form) were normalized to
Xbp1-t (total) levels. All other genes were normalized to
the levels of tubulin. Fold-difference calculations were car-
ried out within the same litter because variation amongBMC Cell Biology 2007, 8:38 http://www.biomedcentral.com/1471-2121/8/38
Page 14 of 16
(page number not for citation purposes)
litters was too large to permit pooling across litters. The
average of the fold-difference values across different litters
from several replicate experiments is presented in Results.
The primer sequences were as follows: Bip, 5'-ACCCT-
TACTCGGGCCAAATT-3', 5'-AGAGCGGAACAGGTC-
CATGT-3'; Chop, 5'-CCAACAGAGGTCACACGCAC-3', 5'-
TGACTGGAATCTGGAGAGCGA-3';  Mac-2, 5'-GATGAA-
GAACCTCCGGGAAAT-3', 5'-GTTATGTCACCACTGATC-
CCCA-3';  Pap, 5'-CCAAAAGAGGCCTGGAGGAC-3', 5'-
GCCTCAGCGCTATTGAGCAC-3';  Reg2, 5'-CTTCCCCTT-
GGCTGAAAAAGA-3', 5'-TCTGGGCAGTTGATTTTGGC-
3';  Reg3g, 5'-ATGCTGCTCTCCTGCCTGAT-3', 5'-
GGCAACTTCACCTTGCACCT-3';  tubulin alpha, 5'-CTT-
GGAACCCACGGTCATC-3', 5'-AAGAGCTGGCGGTAG-
GTGC-3';  Xbp1-s, 5'-GAGTCCGCAGCAGGTG-3', 5'-
GTGTCAGAGTCCATGGGA-3';  Xbp1-t, 5'-CACCTTCTT-
GCCTGCTGGAC-3', 5'-GGGAGCCCTCATATCCACAGT-
3'. Primer sequences for Xbp1-s were previously published
[42].
Real-time PCR for the Perk  gene was carried out as
described previously [15]. The Perk "deleted region" prim-
ers amplify only the wild-type allele, whereas the Perk
"total" primers amplify both wild-type and mutant alleles
(Perk "deleted region", 5'-CAAACAAACCCAGCACCTTT-
3', 5'-CATGGCCTGGCTTATTCTGT-3'; Perk  "total", 5'-
CATTCCTGGAACTGGGAGAA-3', 5'-CTCCATGGGACTC-
CTGGTTA-3'). The reactions were amplified using the
GeneAmp 5700 DNA amplification system and analyzed
with the GeneAmp 5700 SDS software (Applied Biosys-
tems). To calculate the percentage of wild-type Perk allele
remaining in the exPKO mice, the wild-type copy number
estimated for the amplified "deleted region" was normal-
ized to the copy number estimated using the "total" prim-
ers. Genomic DNA from wild-type, heterozygous and
PKO were amplified simultaneously and used as stand-
ards to estimate the deletion frequency within the total
exPKO  pancreas. Theoretically, the percentage of wild-
type allele left for the three standards should be approxi-
mately 100%, 50% and 0% respectively and this is what
was observed.
Microarray
All procedures followed the Affymetrix protocol. Gene-
Chip Mouse Expression Array 430A was used for all sam-
ples. Affymetrix Microarray Suite 5.1 was used to calculate
a difference in gene expression between exPKO and wild-
type at P19 and P32. Detailed methods for sample prepa-
ration and determination of expression differences are
included in Additional Data. Microarray results were
deposited to the Gene Expression Omnibus database
[43]Series #: GSE4422, 4423, 4424; Sample #:
GSM99695, 99696, 99698, 99716, 99762, 99776, 99777,
99780.
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